Home > Cashflow Statement > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-6,710 Cr₹2,376 Cr₹-5,193 Cr₹-5,980 Cr₹-5,715 Cr

What is the latest Cash Flow from Financing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES ?

The latest Cash Flow from Financing Activities ratio of SUN PHARMACEUTICAL INDUSTRIES is ₹-6,710 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-6,710 Cr
Mar2023₹2,376 Cr
Mar2022₹-5,193 Cr
Mar2021₹-5,980 Cr
Mar2020₹-5,715 Cr

How is Cash Flow from Financing Activities of SUN PHARMACEUTICAL INDUSTRIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-6,710 Cr
Negative
Mar2023 ₹2,376 Cr
Positive
Mar2022 ₹-5,193 Cr
Negative
Mar2021 ₹-5,980 Cr
Negative
Mar2020 ₹-5,715 Cr -

Compare Cash Flow from Financing Activities of peers of SUN PHARMACEUTICAL INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES ₹443,018.7 Cr -0.4% 4.7% 60.2% Stock Analytics
DIVIS LABORATORIES ₹144,299.0 Cr -1.1% 11% 43.2% Stock Analytics
CIPLA ₹132,316.0 Cr -1.3% 2.8% 33.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,579.0 Cr -2.3% -7.8% 14.4% Stock Analytics
ZYDUS LIFESCIENCES ₹106,092.0 Cr -5.7% -12.6% 68.7% Stock Analytics
MANKIND PHARMA ₹97,396.6 Cr -2.7% 6.6% 33.4% Stock Analytics


SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMACEUTICAL INDUSTRIES

-0.4%

4.7%

60.2%

SENSEX

0.3%

3%

23.3%


You may also like the below Video Courses